Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

SIMPLE SUMMARY: Immunotherapy has been a successful treatment for many cancers. However, no immunotherapy treatment has been approved for ovarian cancer due to low efficacy in this patient group. This study investigated the cellular and molecular changes from primary ovarian tumors, at the time of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Westergaard, Marie Christine Wulff, Milne, Katy, Pedersen, Magnus, Hasselager, Thomas, Olsen, Lars Rønn, Anglesio, Michael S., Borch, Troels Holz, Kennedy, Mia, Briggs, Gillian, Ledoux, Stacey, Kreuzinger, Caroline, von der Decken, Isabel, Donia, Marco, Castillo-Tong, Dan Cacsire, Nelson, Brad H., Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767114/
https://www.ncbi.nlm.nih.gov/pubmed/33352957
http://dx.doi.org/10.3390/cancers12123828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767114/
https://www.ncbi.nlm.nih.gov/pubmed/33352957
http://dx.doi.org/10.3390/cancers12123828

Ejemplares similares